Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of $0.16, $0.22 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $83.3 million versus the consensus estimate of $84.5 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.